148 related articles for article (PubMed ID: 24923294)
21. Elevated asymmetric dimethylarginine is associated with oxidant stress aggravation in patients with early stage autosomal dominant polycystic kidney disease.
Raptis V; Georgianos PI; Sarafidis PA; Sioulis A; Makedou K; Makedou A; Grekas DM; Kapoulas S
Kidney Blood Press Res; 2013; 38(1):72-82. PubMed ID: 24577239
[TBL] [Abstract][Full Text] [Related]
22. Circulating levels of advanced glycation end products (AGE) and interleukin-6 (IL-6) are independent determinants of serum asymmetric dimethylarginine (ADMA) levels in patients with septic shock.
Nakamura T; Sato E; Fujiwara N; Kawagoe Y; Suzuki T; Ueda Y; Yamada S; Shoji H; Takeuchi M; Ueda S; Matsui T; Adachi H; Okuda S; Yamagishi S
Pharmacol Res; 2009 Dec; 60(6):515-8. PubMed ID: 19450686
[TBL] [Abstract][Full Text] [Related]
23. Comparison of Asymmetric Dimethylarginine Levels Between Stages Three, Four, and Five Non-dialysis of Chronic Kidney Disease.
Asmarawati TP; Widodo ; Thaha M; Aditiawardana ; Mardiana N; Ardhany AR; Tjempakasari A; Santoso D; Pranawa ; Irwanadi C
Acta Med Indones; 2016 Jan; 48(1):28-34. PubMed ID: 27241541
[TBL] [Abstract][Full Text] [Related]
24. Methylated arginine derivatives in children and adolescents with chronic kidney disease.
Brooks ER; Langman CB; Wang S; Price HE; Hodges AL; Darling L; Yang AZ; Smith FA
Pediatr Nephrol; 2009 Jan; 24(1):129-34. PubMed ID: 18830716
[TBL] [Abstract][Full Text] [Related]
25. Circulating levels of asymmetric dimethylarginine are an independent risk factor for left ventricular hypertrophy and predict cardiovascular events in pre-dialysis patients with chronic kidney disease.
Shi B; Ni Z; Zhou W; Yu Z; Gu L; Mou S; Fang W; Wang Q; Cao L; Yan Y; Qian J
Eur J Intern Med; 2010 Oct; 21(5):444-8. PubMed ID: 20816602
[TBL] [Abstract][Full Text] [Related]
26. Asymmetric dimethylarginine in hemodialysis, hemodiafiltration, and peritoneal dialysis.
Eiselt J; Rajdl D; Racek J; Siroká R; Trefil L; Opatrná S
Artif Organs; 2010 May; 34(5):420-5. PubMed ID: 20633156
[TBL] [Abstract][Full Text] [Related]
27. Circulating levels of dimethylarginines, chronic kidney disease and long-term clinical outcome in non-ST-elevation myocardial infarction.
Cavalca V; Veglia F; Squellerio I; De Metrio M; Rubino M; Porro B; Moltrasio M; Tremoli E; Marenzi G
PLoS One; 2012; 7(11):e48499. PubMed ID: 23185262
[TBL] [Abstract][Full Text] [Related]
28. Structure and function of large arteries in hypertension in relation to oxidative stress markers.
Klima Ł; Kawecka-Jaszcz K; Stolarz-Skrzypek K; Menne J; Fijorek K; Olszanecka A; Wojciechowska W; Bilo G; Czarnecka D
Kardiol Pol; 2013; 71(9):917-23. PubMed ID: 24065420
[TBL] [Abstract][Full Text] [Related]
29. Asymmetric dimethylarginine and angiopoietin-like protein-2 are independent predictors of cardiovascular risk in pre-dialysis non-diabetic chronic kidney disease patients.
Ashokachakkaravarthy K; Rajappa M; Parameswaran S; Satheesh S; Priyadarshini G; Mohan Raj PS; Revathy G; Priyadarssini M
Int Urol Nephrol; 2020 Jul; 52(7):1321-1328. PubMed ID: 32409974
[TBL] [Abstract][Full Text] [Related]
30. Chronic renal impairment and DDAH2-1151 A/C polymorphism determine ADMA levels in type 2 diabetic subjects.
Marra M; Marchegiani F; Ceriello A; Sirolla C; Boemi M; Franceschi C; Spazzafumo L; Testa I; Bonfigli AR; Cucchi M; Testa R
Nephrol Dial Transplant; 2013 Apr; 28(4):964-71. PubMed ID: 23129820
[TBL] [Abstract][Full Text] [Related]
31. Advanced oxidative protein products are independently associated with endothelial function in peritoneal dialysis patients.
Kocak H; Gumuslu S; Sahin E; Ceken K; Gocmen YA; Yakupoglu G; Ersoy FF; Tuncer M
Nephrology (Carlton); 2009 Apr; 14(3):273-80. PubMed ID: 19076287
[TBL] [Abstract][Full Text] [Related]
32. Effect of inflammation by acute sepsis on intact fibroblast growth factor 23 (iFGF23) and asymmetric dimethyl arginine (ADMA) in CKD patients.
Dounousi E; Torino C; Pizzini P; Cutrupi S; Panuccio V; D'Arrigo G; Abd ElHafeez S; Tripepi G; Mallamaci F; Zoccali C
Nutr Metab Cardiovasc Dis; 2016 Jan; 26(1):80-3. PubMed ID: 26712271
[No Abstract] [Full Text] [Related]
33. Asymmetric dimethylarginine (ADMA) induces chronic kidney disease through a mechanism involving collagen and TGF-β1 synthesis.
Mihout F; Shweke N; Bigé N; Jouanneau C; Dussaule JC; Ronco P; Chatziantoniou C; Boffa JJ
J Pathol; 2011 Jan; 223(1):37-45. PubMed ID: 20845411
[TBL] [Abstract][Full Text] [Related]
34. Serum asymmetric dimethylarginine and arginine levels predict microvascular and macrovascular complications in type 2 diabetes mellitus.
Ganz T; Wainstein J; Gilad S; Limor R; Boaz M; Stern N
Diabetes Metab Res Rev; 2017 Feb; 33(2):. PubMed ID: 27393712
[TBL] [Abstract][Full Text] [Related]
35. HPLC determination of plasma dimethylarginines: method validation and preliminary clinical application.
Ivanova M; Artusi C; Boffa GM; Zaninotto M; Plebani M
Clin Chim Acta; 2010 Nov; 411(21-22):1632-6. PubMed ID: 20542018
[TBL] [Abstract][Full Text] [Related]
36. Dimethylarginines as risk markers of atherosclerosis and chronic kidney disease in children with nephrotic syndrome.
Hyla-Klekot L; Bryniarski P; Pulcer B; Ziora K; Paradysz A
Adv Clin Exp Med; 2015; 24(2):307-14. PubMed ID: 25931365
[TBL] [Abstract][Full Text] [Related]
37. Association between Asymmetric Dimethylarginine and Pentosidine in Dialysis Effluent of Peritoneal Dialysis Patients -A possible intraperitoneal crosstalk between asymmetric dimethylarginine and advanced glycation end products in peritoneal dialysis patients.
Ishida M; Kakuta T; Miyakogawa T; Tatsumi R; Matsumoto C; Fukagawa M
Tokai J Exp Clin Med; 2016 Jun; 41(2):97-100. PubMed ID: 27345001
[TBL] [Abstract][Full Text] [Related]
38. Variability in estimated glomerular filtration rate values is a risk factor in chronic kidney disease progression among patients with diabetes.
Tseng CL; Lafrance JP; Lu SE; Soroka O; Miller DR; Maney M; Pogach LM
BMC Nephrol; 2015 Mar; 16():34. PubMed ID: 25885708
[TBL] [Abstract][Full Text] [Related]
39. Sympathetic nerve traffic and asymmetric dimethylarginine in chronic kidney disease.
Grassi G; Seravalle G; Ghiadoni L; Tripepi G; Bruno RM; Mancia G; Zoccali C
Clin J Am Soc Nephrol; 2011 Nov; 6(11):2620-7. PubMed ID: 21940841
[TBL] [Abstract][Full Text] [Related]
40. The determinants of endothelial dysfunction in CKD: oxidative stress and asymmetric dimethylarginine.
Yilmaz MI; Saglam M; Caglar K; Cakir E; Sonmez A; Ozgurtas T; Aydin A; Eyileten T; Ozcan O; Acikel C; Tasar M; Genctoy G; Erbil K; Vural A; Zoccali C
Am J Kidney Dis; 2006 Jan; 47(1):42-50. PubMed ID: 16377384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
